Pathobiology 2027

Mechanisms of Disease

May 1-4, 2027

Flamingo Las Vegas, Las Vegas, NW

Session 004 – Cardio-Oncology: Mechanisms and Prevention

10:30 AM-12:15 PM
Sponsored by the ASIP Cardiac and Vascular Pathobiology Scientific Interest Group and the ASIP Neoplasia, Tumor Microenvironment, and Metastasis Scientific Interest Group
Session Room: TBD

Session Co-Chairs

Traci Perry

Traci Parry, PhD
University of North Carolina, Greensboro

Maria Antonia Zambrano

Maria Zambrano
Tufts University

Session Overview

This session delves into the molecular and cellular mechanisms underlying cardiovascular toxicity induced by anti cancer therapies, focusing on how targeted agents and chemotherapeutics disrupt cardiomyocyte signaling, mitochondrial integrity, and stress response pathways. Speakers will outline emerging frameworks that explain differential susceptibility to cardiac injury, including maladaptive kinase activation, oxidative stress, and metabolic dysfunction. This session also examines how lifestyle based interventions modulate these pathways, highlighting evidence that exercise holds value as an adjuvant therapy for attenuating treatment induced toxicity.

Agenda

  • Co-Chair – Welcome and Introductions

  • Brian Jensen10:30-10:55 AM
    MEK Inhibitor Cardiotoxicity: From MEKanism to Clinical Prediction
    Brian Jensen, MD
    University of North Carolina

  • Ashley Smuder10:55-11:20 AM
    Exercise as a Strategy to Mitigate Chemotherapy-Related Cardiotoxicity
    Ashley Smuder, PhD
    University of Florida

  • Keri Schadler11:20-11:45 AM
    Lifestyle Interventions for Toxicity Mitigation
    Keri Schadler, PhD
    The University of Texas MD Anderson Cancer Center

  • 11:45 AM-12:00 PM
    Abstract 1

  • 12:00-12:15 PM
    Abstract 2